Anxiety Disorders Referenced in Castonguay, Chapter 4:
Panic Disorder
Characterized by recurrent panic attacks with a rapid onset of physical symptoms.
Symptoms may include:
Racing heart
Shortness of breath
Accompanied by a fear of future attacks.
Agoraphobia
Involves avoidance of situations where panic or anxiety might occur, especially when escape may be difficult.
Social Anxiety (Social Phobia)
Intense anxiety or avoidance of social situations due to fear of negative evaluation.
Specific Phobias
Excessive fear of specific objects or situations (e.g., spiders, heights, enclosed spaces).
Overlap of Symptoms
Many symptoms across various anxiety disorders are overlapping, suggesting a need for a dimensional model that could better explain the range of anxiety problems rather than a rigid DSM category system.
Typical Symptoms and Clinical Features
Excessive Distress:
Often disproportionate to the objective danger present in the environment.
Avoidance Behaviors:
Individuals may attempt to escape or avoid certain feared situations, resulting in functional impairments (socially or occupationally).
Information Processing:
Anxious individuals may process information in a manner that reinforces negative beliefs about the world and its dangers.
Physiological Reactions:
Commonality of a “fight or flight” reaction across anxiety disorders characterized by autonomic arousal.
Sympathetic Nervous System Activation:
Pathophysiology Includes:
Increased heart rate
Rapid breathing
Inhibition of digestive processes
Vasoconstriction in certain body areas and vasodilation in muscles.
Pupil dilation
Release of endorphins
Acceleration of reflexes.
Autonomic Nervous System
Sympathetic Nervous System:
Role:
Responsible for the “fight or flight” response, preparing the body for potential danger.
Characteristics:
Short neuron pathways for rapid response.
Increases in heartbeat; muscle tension.
Pupil dilation for enhanced visual clarity.
Saliva secretion is inhibited.
Parasympathetic Nervous System:
Role:
Involved in homeostasis and the “rest and digest” response.
Characteristics:
Long neuron pathways, resulting in slower response times.
Reduces heartbeat; muscle relaxation.
Pupil constriction; increased saliva secretion;
Promotes digestive processes.
Anxiety Disorders as per DSM-5-TR
Categories:
Separation Anxiety Disorder
Selective Mutism
Specific Phobia
Social Anxiety Disorder
Panic Disorder
Agoraphobia
Generalized Anxiety Disorder
Substance/Medication-Induced Anxiety Disorder
Anxiety Disorder Due to Another Medical Condition
Other Specified Anxiety Disorder.
Illness Course: Panic Disorder and Agoraphobia
Panic Attack Patterns:
Attacks may vary in frequency (waxing and waning).
Life stressors can predict both the onset and frequency of episodes.
Generally, these conditions are chronic and disabling; relapse after remission is common.
Longitudinal Findings:
In a 5-year follow-up study:
38% in remission
44% with mild symptoms and phobic avoidance
19% relapsed or unchanged.
Summary: Indicates that residual symptoms are common, and relapse is expected.
Illness Course: Social Anxiety Disorder
Chronic Nature:
Tends to persist, with low recovery rates and high rates of recurrence, especially when untreated.
Estimates suggest duration anywhere between 19 and 30 years.
Naturalistic recovery rates are low, ranging from 20-40%.
Prospective studies suggest only a 37% chance of recovery over 12 years with a 39% chance of recurrence after recovery.
Conclusion: Social anxiety disorder is often long-lasting and may remain untreated without intervention.
Illness Course: Specific Phobia
Stability:
Not much data available; however, some phobias in adults appear stable when untreated.
Many children tend to outgrow phobias over time.
Seeking treatment is rare, but those who do often benefit from therapies like exposure therapy.
Epidemiology
Past Year Prevalence (U.S. Adults 2001-2003)
Data sourced from the National Comorbidity Survey Replication (NCS-R):
Overview of anxiety disorders in adults by sex and age.
Approx rates with noted variations across demographics.
Graph Analysis: Displayed percentage data on various demographics (female, male, and age categories).
Lifetime Prevalence Among Adolescents (2001-2004)
Data sourced from the National Comorbidity Survey Adolescent Supplement (NCS-A):
Insights into prevalence in adolescent groups.
Overall rates and severe impairments broken down by age groups.
Past Year Severity of Anxiety Disorders (U.S. Adults 2001-2003)
Severity categories compiled via NCS-R, indicating serious, moderate, and mild instances.
Statistics:
Serious: 22.8%
Moderate: 33.7%
Mild: 43.5%
Epidemiology: Panic Disorder and Agoraphobia
Lifetime Prevalence:
Ranges from 3.8% to 4.7% for panic disorder (with or without agoraphobia).
1-year prevalence estimates between 1.8% and 2.4%.
Agoraphobia without panic occurs in approximately 2.5% lifetime prevalence.
Median age of onset: 24.
Notable Puberty as predictor for panic attacks, new onset in older adults often linked to life stressors.
Gender disparity consistently reports a ratio of approximately 2:1 (women to men).
Comparison across cultures shows consistency in prevalence rates and onset age.
Epidemiology: Social Anxiety Disorder
Lifetime Prevalence:
Estimated between 3 and 13% in Western cultures, with the NCS-R indicating 12.1%.
Median age of onset is typically 13 years, with rates decreasing into later life.
Notable prevalence differences observed across sexes and treatments.
Cultural impacts reveal lower prevalence in Southeast Asian countries compared to Western standards.
Epidemiology: Specific Phobia
Variation in Prevalence:
Lifetime prevalence ranges from 6 to 12%.
Some individuals report sub-clinical fears; common fears include animals and heights.
Mean onset age is noted at 8 years old, with variations in phobia types (e.g., blood-injury phobia often noted in childhood).
Highest prevalence occurs in childhood/adolescence, with stability observed in adulthood until mid-50s.
Similar to other anxiety disorders, more prevalent among women; treatment-seeking studies indicate higher success rates for women.
Comorbidity Considerations
Panic Disorder and Agoraphobia
Comorbid Disorders:
Approximately 83% of individuals with panic disorder have at least one additional psychiatric disorder.
Notably, 20% meet criteria for agoraphobia, particularly higher in clinical settings.
High occurrence with anxiety disorders (e.g., generalized anxiety disorder and specific phobias).
Common mood disorder comorbidities include major depression in about 35-40% of individuals with panic disorder.